3-(aminomethyl)-N-[2-[(3,4-dimethoxyphenyl)methyl]-5-methylpyrazol-3-yl]pyrrolidine-1-carboxamide
C19H27N5O3 — CID 118787317
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(aminomethyl)-N-[2-[(3,4-dimethoxyphenyl)methyl]-5-methylpyrazol-3-yl]pyrrolidine-1-carboxamide
3-(aminomethyl)-N-[2-[(3,4-dimethoxyphenyl)methyl]-5-methylpyrazol-3-yl]pyrrolidine-1-carboxamide (PubChem CID 118787317) has the molecular formula C19H27N5O3 and a molecular weight of 373.46 g/mol. Its IUPAC name is 3-(aminomethyl)-N-[2-[(3,4-dimethoxyphenyl)methyl]-5-methylpyrazol-3-yl]pyrrolidine-1-carboxamide.
Molecular Properties
| Compound Name | 3-(aminomethyl)-N-[2-[(3,4-dimethoxyphenyl)methyl]-5-methylpyrazol-3-yl]pyrrolidine-1-carboxamide |
|---|---|
| PubChem CID | 118787317 |
| Molecular Formula | C19H27N5O3 |
| Molecular Weight | 373.46 g/mol |
| Exact Mass | 373.21 |
| IUPAC Name | 3-(aminomethyl)-N-[2-[(3,4-dimethoxyphenyl)methyl]-5-methylpyrazol-3-yl]pyrrolidine-1-carboxamide |
| SMILES | COc1ccc(Cn2nc(C)cc2NC(=O)N2CCC(CN)C2)cc1OC |
| InChI | InChI=1S/C19H27N5O3/c1-13-8-18(21-19(25)23-7-6-15(10-20)11-23)24(22-13)12-14-4-5-16(26-2)17(9-14)27-3/h4-5,8-9,15H,6-7,10-12,20H2,1-3H3,(H,21,25) |
| InChIKey | CEDIJUIMNRQIHC-UHFFFAOYSA-N |
| XLogP | 2.07 |
| TPSA | 94.64 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 373.46 |
| LogP ≤ 5 | 2.07 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118787317 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.